SCHEMBL7279944

SCHEMBL7279944

CNCCS[C@H]1CC[C@@]2(C)[C@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](C4=CC(=O)OC4)CC[C@]32O)C1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATP1A1 P05023 12/20 0.68
ATP1B1 P05026 12/20 0.68
ATP1A3 P13637 12/20 0.68
ATP1B2 P14415 12/20 0.68
ATP1A2 P50993 12/20 0.68
ATP1B3 P54709 12/20 0.68
FXYD2 P54710 12/20 0.68
ATP1A4 Q13733 12/20 0.68
TP53 P04637 5/20 0.68
LMNA P02545 3/20 0.68
SMN1; SMN2 Q16637 3/20 0.68
RAB9A P51151 3/20 0.68
PAX8 Q06710 2/20 0.68
NPC1 O15118 2/20 0.68
CYP3A4 P08684 1/20 0.68
TSHR P16473 1/20 0.68
HIF1A Q16665 1/20 0.68
ATP12A P54707 1/20 0.68
HBB P68871 1/20 0.54
USP2 O75604 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7279884 0.91 ATP1A1 (0.71) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
SCHEMBL7276903 0.90 ATP1A1 (0.70) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
SCHEMBL7278080 0.90 ATP1A1 (0.63) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
SCHEMBL7276870 0.89 ATP1A1 (0.69) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
SCHEMBL7279424 0.89 ATP1A1 (0.69) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
SCHEMBL7279753 0.89 ATP1A1 (0.69) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
SCHEMBL7277089 0.87 ATP1A1 (0.71) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
Oxalic Acid SCHEMBL7286132 0.87 ATP1A1 (0.66) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
Oxalic Acid SCHEMBL7286625 0.86 ATP1A1 (0.65) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
SCHEMBL7277854 0.86 ATP1A1 (0.65) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0576913-B1 Digitoxigenin and dihydrodigitoxigenin 3beta-derivatives and pharmaceutical compositions comprising same for the treatment of hypertension. SIGMA TAU IND FARMACEUTI (IT) 1997-09-03 EP claimed
EP-0576913-A2 Digitoxigenin and dihydrodigitoxigenin 3beta-derivatives and pharmaceutical compositions comprising same for the treatment of cardiovascular disorders Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) 1994-01-05 EP claimed
EP-0576913-B1 Digitoxigenin and dihydrodigitoxigenin 3beta-derivatives and pharmaceutical compositions comprising same for the treatment of hypertension. SIGMA TAU IND FARMACEUTI (IT) 1997-09-03 EP disclosed
US-5478817-A Treatment of hypertension, heart failure SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 1995-12-26 US disclosed
EP-0576913-A2 Digitoxigenin and dihydrodigitoxigenin 3beta-derivatives and pharmaceutical compositions comprising same for the treatment of cardiovascular disorders Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) 1994-01-05 EP disclosed